TradesZ
Top 10 stocks to add now
← All stocks
BSX

BSX — BOSTON SCIENTIFIC CORP

CIK 885725 · SEC EDGAR fundamentals

Latest 10-K filed February 17, 2026 · period ending December 31, 2023

Smart money in BSX

Famous investors holding it (13F) + members of Congress who disclosed trading it (STOCK Act). Public SEC data.

How we track smart money →

13F shows long U.S. positions per the filing date; congressional trades are member-disclosed under the STOCK Act. Informational, not advice.

Headline figures

Revenue
$7.46B
+5.5% vs prior year

Top-line sales for the most-recent fiscal year

FY2016 · 10-K

Net income

Profit after all expenses, taxes, interest

EPS (diluted)
$1.07
+137.8% vs prior year

Net income per diluted share outstanding

FY2025 · 10-K

Op. cashflow
$2.50B
+64.0% vs prior year

Cash actually generated by the business

FY2025 · 10-K

Balance sheet

Total assets
$39.40B

Everything the company owns

FY2025 · 10-K

Total liabilities

Everything the company owes

Stockholders equity
$21.77B

Assets minus liabilities (book value)

FY2025 · 10-K

Long-term debt
$5.42B

Debt due more than 12 months out

FY2017 · 10-K

Revenue history

Revenues · FY values from Revenues

Fiscal year Revenue vs prior Source
FY2016 $7.46B +5.5% 10-K
FY2015 $7.07B +1.6% 10-K
FY2014 $6.96B 10-K

Read the source

All figures on this page were filed by BOSTON SCIENTIFIC CORP with the SEC and pulled directly from EDGAR's XBRL CompanyFacts API. Click below to view the latest annual report (10-K) in full.

Open latest 10-K on SEC EDGAR →

Data sources & methodology

All figures derive from official, public-domain government filings. Read our methodology for how we collect, process and score this data. See the methodology →

TZ Researched & published by TradesZ Research

Not investment advice. Figures sourced from the SEC's XBRL CompanyFacts API — public-domain federal records. Companies occasionally restate prior-year numbers; we show the latest filed value per fiscal year.